Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
Publication Year 2019-02-15,Volume 10,Issue #1,Page 766
Journal Title
Nature Communications
Publication Type
Journal Article
Primary triple negative breast cancers (TNBC) are prone to dissemination but sub-clonal relationships between tumors and resulting metastases are poorly understood. Here we use cellular barcoding of two treatment-naive TNBC patient-derived xenografts (PDXs) to track the spatio-temporal fate of thousands of barcoded clones in primary tumors, and their metastases. Tumor resection had a major impact on reducing clonal diversity in secondary sites, indicating that most disseminated tumor cells lacked the capacity to 'seed', hence originated from 'shedders' that did not persist. The few clones that continued to grow after resection i.e. 'seeders', did not correlate in frequency with their parental clones in primary tumors. Cisplatin treatment of one BRCA1-mutated PDX model to non-palpable levels had a surprisingly minor impact on clonal diversity in the relapsed tumor yet purged 50% of distal clones. Therefore, clonal features of shedding, seeding and drug resistance are important factors to consider for the design of therapeutic strategies.
Springer Nature
WEHI Research Division(s)
Immunology; Bioinformatics; Cancer Biology And Stem Cells
PubMed ID
Terms of Use/Rights Notice
Refer to copyright notice on published article.

Creation Date: 2019-03-13 11:54:09
Last Modified: 2019-03-13 02:01:03
An error has occurred. This application may no longer respond until reloaded. Reload 🗙